Last reviewed · How we verify

NCT06461962: PEER-Heart

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Recruiting now NA Last updated 21 March 2025
What this trial tests

NA trial testing Treatment as Usual in Methamphetamine Use in 200 participants. Currently enrolling.

Timeline
19 August 2024
Primary endpoint
30 June 2029
30 June 2029

Quick facts

Lead sponsorOregon Health and Science University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment200
Start date19 August 2024
Primary completion30 June 2029
Estimated completion30 June 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Oregon Health and Science University

Who can join

18 and older, any sex, with Methamphetamine Use or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Treatment as Usual

Trials testing the same drug.

Other recruiting trials for Methamphetamine Use

Currently open trials in the same condition.

Other Oregon Health and Science University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06461962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing